Morgan Stanley, MUFG Support Bristol-Myers Squibb/Celgene Merger

Bristol-Myers Squibb agreed to acquire biopharmaceutical company Celgene in a $74 billion cash and stock transaction. Morgan Stanley Senior Funding and MUFG Bank will provide the debt financing to support the transaction.